Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Although there are molecularly distinct subtypes of prostate cancer, no molecular classification system is used clinically. The ribonucleotide reductase small subunit M2 (RRM2) gene plays an oncogenic role in many cancers. Our previous study elucidated comprehensive molecular mechanisms of RRM2 in p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ying Z. Mazzu, Joshua Armenia, Subhiksha Nandakumar, Goutam Chakraborty, Yuki Yoshikawa, Lina E. Jehane, Gwo‐Shu Mary Lee, Mohammad Atiq, Nabeela Khan, Nikolaus Schultz, Philip W. Kantoff
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2020-08-01
Colecção:	Molecular Oncology
Assuntos:	molecular subtyping PAM50 PCS subtyping prostate cancer RRM2
Acesso em linha:	https://doi.org/10.1002/1878-0261.12706
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!